» Authors » Devjit Tripathy

Devjit Tripathy

Explore the profile of Devjit Tripathy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 4256
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen X, Tripathy D, Chilton R, Hansis-Diarte A, Salehi M, Solis-Herrera C, et al.
Diabetes . 2024 Mar; 73(6):896-902. PMID: 38512770
Article Highlights:
2.
Salehi M, Peterson R, Tripathy D, Pezzica S, DeFronzo R, Gastaldelli A
Obesity (Silver Spring) . 2023 Oct; 31(11):2774-2785. PMID: 37853989
Objective: Prandial hyperinsulinemia after Roux-en-Y gastric bypass surgery (GB), and to lesser degree after sleeve gastrectomy (SG), has been attributed to rapid glucose flux from the gut and increased insulinotropic...
3.
Salehi M, Tripathy D, Peterson R, Honka H, Pezzica S, DeFronzo R, et al.
Diabetes . 2023 Jul; 72(10):1374-1383. PMID: 37467435
Article Highlights: Rerouted gut after Roux-en-Y gastric bypass (GB) and, to a lesser degree, after sleeve gastrectomy (SG) leads to larger glucose excursion and lower nadir glucose, predisposing individuals to...
4.
Barrea L, Vetrani C, Verde L, Frias-Toral E, Ceriani F, Cernea S, et al.
Antioxidants (Basel) . 2023 Apr; 12(4). PMID: 37107279
In the pathogenesis of type 2 diabetes mellitus (T2DM), diet plays a key role. Individualized medical nutritional therapy, as part of lifestyle optimization, is one of the cornerstones for the...
5.
Salehi M, Peterson R, Tripathy D, Pezzica S, DeFronzo R, Gastaldelli A
medRxiv . 2023 Apr; PMID: 37034666
Background/aims: Prandial hyperinsulinemia after Roux-en Y gastric bypass surgery (GB), and to lesser degree after sleeve gastrectomy (SG), has been attributed to rapid glucose flux from the gut and increased...
6.
Chen X, Merovci A, DeFronzo R, Tripathy D
Metabolism . 2023 Feb; 142:155512. PMID: 36746320
Background And Aims: Hyperglucagonemia is a characteristic feature of type 2 diabetes mellitus (T2DM). We examined the effect of chronic (48-72 h) physiologic increase (+50 mg/dl) in plasma glucose concentration...
7.
Shannon C, Merovci A, Fourcaudot M, Tripathy D, Abdul-Ghani M, Wang H, et al.
J Clin Endocrinol Metab . 2022 May; 107(8):e3177-e3185. PMID: 35552423
Context: Sustained increases in plasma glucose promote skeletal muscle insulin resistance independent from obesity and dyslipidemia (ie, glucotoxicity). Skeletal muscle lipids are key molecular determinants of insulin action, yet their...
8.
Palavicini J, Chavez-Velazquez A, Fourcaudot M, Tripathy D, Pan M, Norton L, et al.
Front Physiol . 2021 Dec; 12:784391. PMID: 34925073
The insulin-sensitizer pioglitazone exerts its cardiometabolic benefits in type 2 diabetes (T2D) through a redistribution of body fat, from ectopic and visceral areas to subcutaneous adipose depots. Whereas excessive weight...
9.
10.
Tripathy D, Solis-Herrera C, Ryder R
Diabetes Spectr . 2021 Sep; 34(3):243-247. PMID: 34511850
Antidiabetic medications that improve glycemic control as well as cardiovascular outcomes will be the mainstay of treatment for type 2 diabetes moving forward. This article reviews the beneficial effects of...